Cuorips (TSE:4894) Operating Margin %: -2,985.34% (As of Mar. 2026)


TSE:4894 Cuorips Inc TSE:4894
69 GF Score
Price 円3,855.00
GF Value 円28,569.75
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Cuorips Operating Margin %?

Cuorips TSE:4894 -1.15% 69 Operating Margin % is -2,985.34% as of Mar. 2026. GuruFocus rates TSE:4894 with a GF Score™ of 69/100 and a GF Value™ of 円28,569.75 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 944 Biotechnology companies, Cuorips ranks worse than 70.44% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Cuorips's Operating Income for the six months ended in Mar. 2026 was 円-585.9 Mil. Cuorips's Revenue for the six months ended in Mar. 2026 was 円19.6 Mil. Therefore, Cuorips's Operating Margin % for the quarter that ended in Mar. 2026 was -2,985.34%.

Good Sign:

Cuorips Inc operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Cuorips's Operating Margin % or its related term are showing as below:

TSE:4894' s Operating Margin % Range Over the Past 10 Years
Min: -128109.55   Med: -1862.05   Max: -336.9
Current: -509.23


TSE:4894's Operating Margin % is ranked worse than
70.44% of 944 companies
in the Biotechnology industry
Industry Median: -86.83 vs TSE:4894: -509.23

Cuorips's 5-Year Average Operating Margin % Growth Rate was 61.20% per year.

Cuorips's Operating Income for the six months ended in Mar. 2026 was 円-585.9 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,081.3 Mil.


Cuorips  (TSE:4894) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Cuorips Operating Margin % Related Terms


Cuorips Operating Margin % Historical Data

* Premium members only.

The historical data trend for Cuorips's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuorips Operating Margin % Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Margin %
Get a 7-Day Free Trial -2,682.85 -1,176.75 -2,547.34 -336.90 -509.23

Cuorips Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only -2,633.11 -5,051.24 -114.50 -257.04 -2,985.34

TSE:4894 vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, Cuorips's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cuorips Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cuorips's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Cuorips's Operating Margin % falls into.


TSE:4894
69GF Score
Cuorips Inc TSE:4894
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuorips Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Cuorips's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=-1081.267 / 212.332
=-509.23 %

Cuorips's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-585.932 / 19.627
=-2,985.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -2,985.34% mean?
Cuorips (TSE:4894) has a Operating Margin % of -2,985.34% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Cuorips and its competitors. According to the industry distribution chart, Cuorips ranks #665 out of 944 companies in the Biotechnology industry, placing it in the top 70.4%.
Is Cuorips' Operating Margin % too high?
Cuorips' current Operating Margin % is -2,985.34%. Based on the distribution chart, Cuorips ranks #665 out of 944 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Cuorips has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cuorips' Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cuorips ranks #665 out of 944 companies for Operating Margin %. This places Cuorips in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Cuorips and its competitors. Cuorips's current Operating Margin % is -2,985.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuorips stock overvalued right now?
Based on GuruFocus' analysis, Cuorips (TSE:4894) is currently considered Possible Value Trap. The stock's GF Value™ is 円28,569.75, compared to a current price of 円3,855.00 — trading 86.5% below its estimated fair value. The current Operating Margin % is -2,985.34%. Cuorips' overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Cuorips (TSE:4894), the current Operating Margin % is -2,985.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cuorips (TSE:4894) Overvalued in 2026?

Based on GuruFocus' analysis, Cuorips stock appears to be undervalued. The current stock price of 円3,855.00 is trading 86.5% below its estimated GF Value™ of 円28,569.75. GuruFocus considers Cuorips to be Possible Value Trap.

Key valuation signals for TSE:4894:

  • Operating Margin %: -2,985.34%
  • GF Value™: 円28,569.75 vs. price of 円3,855.00 (86.5% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the TSE:4894 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cuorips Business Description

Address 3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.
69GF Score

Get the complete analysis for TSE:4894

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,855.00
Price
円28,569.75
GF Value